Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Intermediate
N-Formylnornicotine serves as a crucial intermediate in the synthesis pathway from Nornicotine to nicotine. Its role is essential for researchers exploring nicotine biosynthesis and its derivatives. This compound is valuable in the production of nicotine-related products in pharmacological research and development. -
Drug Intermediate
7-Chlorothieno[2,3-c]pyridine functions as a synthetic intermediate in pharmaceutical synthesis. Its unique thieno and pyridine structural elements facilitate the development of various bioactive compounds. This reagent is instrumental in the preparation of potential therapeutic agents, particularly in exploring novel pathways for drug discovery and development. -
Drug Impurity
Nizatidine impurity 1 is a known impurity associated with the histamine H2 receptor antagonist Nizatidine. It serves as a reference standard for quality control and analytical testing in pharmaceutical development. This reagent is utilized in the investigation of drug purity, stability studies, and regulatory compliance assessments in the production of Nizatidine. -
Drug Impurity
Apixaban impurity 1 is a known impurity associated with the anticoagulant drug Apixaban, primarily functioning as a factor Xa inhibitor. This compound is essential for analytical and quality control studies related to the synthesis and purity assessment of Apixaban. It serves as a reference standard in research applications focusing on drug development, formulation stability, and impurity profiling. -
Drug Impurity
2-Chloro-5-nitrobenzoic acid is identified as a related impurity in the synthesis of Mesalazine. This compound serves as a significant marker in assessing the purity and quality of the pharmaceutical formulation. Its detection and quantification are crucial for evaluating drug safety and efficacy, making it valuable in chemical analysis and regulatory compliance in pharmaceutical research. -
Drug Intermediate
1,1'-(Butane-1,4-diyl)bis(3-(2-(2-(2-aminoethoxy)ethoxy)ethyl)urea) dihydrochloride serves as a valuable drug intermediate in the synthesis of diverse active pharmaceutical compounds. Its unique structural configuration facilitates the development of bioactive molecules with therapeutic potential. This reagent is applicable in organic synthesis and medicinal chemistry for the creation of novel drug candidates. -
Drug Impurity
Afatinib impurity 4 is a characterized impurity of the EGFR inhibitor Afatinib, which is utilized in cancer therapeutics. This compound serves as an important standard in analytical chemistry, allowing for the assessment of drug purity and the monitoring of impurities during the drug development process. Its relevance in pharmacokinetics and toxicology studies makes it essential for researchers working on related drug formulations. -
Drug Impurity
Diclofenac impurity 8, also known as Diclofenac impurity B, is a drug impurity associated with the nonsteroidal anti-inflammatory drug Diclofenac. This compound can be used in research to study the stability and degradation pathways of Diclofenac formulations. Investigating such impurities is essential for understanding potential safety and efficacy implications in pharmaceutical development. -
Drug Intermediate
1-Methyl-4-(2,4,6-trimethoxyphenyl)piperidin-3-ol serves as a crucial drug intermediate in the synthesis of diverse bioactive compounds. Its structural properties facilitate the development of pharmaceuticals targeting various biological pathways, enabling researchers to explore new therapeutic options. This compound is essential for studies focusing on medicinal chemistry and the generation of novel drug candidates. -
Drug Impurity
Irbesartan impurity 4, also known as Losartan Dibromo Impurity, is a chemical impurity related to the angiotensin II receptor antagonist, Irbesartan. This compound serves as a reference standard in the analysis of Irbesartan formulations, allowing for the detection and quantification of impurities during quality control and stability studies. Its characterization is essential for ensuring the safety and efficacy of pharmaceutical products containing Irbesartan. -
Drug Impurity
Terbinafine impurity 1 (N-Methyl-1-naphthylmethylamine) is a known impurity associated with the antifungal agent terbinafine. This compound serves as an important reference material for analytical method development and quality control in pharmaceutical research. Its identification and quantification are crucial for ensuring the purity and efficacy of terbinafine formulations. -
Drug Impurity
Raloxifene impurity 7 is a byproduct associated with the synthesis of Raloxifene, a selective estrogen receptor modulator (SERM). Its chemical profile is important for understanding the purity and quality of Raloxifene formulations. This impurity can be utilized in stability studies, method validation, and compliance testing within pharmaceutical research settings. -
Drug Impurity
Oseltamivir impurity 68 is a chemical impurity associated with Oseltamivir, an antiviral medication primarily targeting the influenza virus. This compound is significant for analytical chemistry and quality control in pharmaceutical research and development. Its characterization aids in ensuring the purity and efficacy of Oseltamivir formulations. -
Drug Impurity
Sorafenib Impurity 4 is a defined impurity associated with Sorafenib, primarily known for its role in targeting multiple kinases involved in cell proliferation and angiogenesis. This impurity is crucial for analytical studies and method development in quality control processes. It is essential for researchers investigating the purity and stability of Sorafenib formulations, ensuring compliance with regulatory standards in pharmaceutical development. -
Drug Impurity
Ticagrelor impurity 6 is a characterized impurity of the antiplatelet agent Ticagrelor, primarily utilized in pharmacological research and quality control. This compound can serve as a reference standard for identifying and quantifying related substances in Ticagrelor formulations. Its analysis is essential for ensuring the purity and stability of Ticagrelor in clinical settings and pharmaceutical formulations. -
Drug Intermediate
2-(3-(Trifluoromethyl)benzamido)acetic acid serves as a crucial drug intermediate in the synthesis of diverse bioactive compounds. Its unique chemical structure facilitates the formation of various derivatives with potential therapeutic applications. This compound is instrumental in medicinal chemistry research and the development of novel pharmaceuticals targeting specific biological mechanisms. -
Drug Intermediate
Silane, [[(1a,3b,5E,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraene-1,3-diyl]bis(oxy)]bis[(1,1-dimethylethyl)dimethyl- serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical compounds. Its distinctive structural features facilitate the formation of various bioactive moieties, making it essential for research in medicinal chemistry. This reagent enables the exploration and development of novel therapeutic agents, contributing to advancements in drug discovery and development. -
Drug Impurity
3-(2,3-Dihydrobenzofuran-7-yl)acrylic acid serves as a drug impurity that can be encountered in pharmaceutical research and development processes. This compound may potentially influence drug formulation stability and efficacy assessments. Its structural attributes are crucial for studies focused on impurity profiling, safety evaluations, and compliance with regulatory standards in drug development. -
Drug Intermediate
Boc-D-Phe-Pro-OH is a tert-Butoxycarbonyl-D-phenylalanyl-L-proline compound that serves as a valuable drug intermediate in pharmaceutical synthesis. This reagent plays a crucial role in the development of peptide-based therapeutics, enabling the construction of complex molecular architectures. Its utility in synthetic organic chemistry makes it indispensable for researchers focused on drug design and development. -
Drug Impurity
Tandospirone impurity 4 is a structural impurity associated with Tandospirone, a therapeutic agent primarily used for its anxiolytic properties. This impurity serves as an important reference standard in quality control and analytical applications to ensure the purity and safety of Tandospirone formulations. Its characterization is essential in pharmaceutical development and regulatory compliance. -
Drug Impurity
Vonoprazan impurity 7 is a chemical impurity associated with the proton pump inhibitor Vonoprazan. This compound may be used in the evaluation of drug purity and stability, contributing to the assessment of pharmaceutical quality and regulatory compliance. It serves as a reference standard in analytical chemistry for the characterization and quantification of Vonoprazan-related substances in research applications. -
Drug Intermediate
Methyl pyrimidine-4-carboxylate is a synthetic intermediate primarily used in pharmaceutical synthesis. This compound serves as a versatile building block in the development of various bioactive molecules and is instrumental in the preparation of pyrimidine derivatives. Its chemical structure allows for further functionalization, making it valuable in medicinal chemistry and drug discovery applications. -
Impurity of Asenapine
Asenapine impurity 1 is a recognized impurity of Asenapine, an atypical antipsychotic known for its antagonistic activity on serotonin, adrenoceptors, dopamine, and histamine receptors. With reported pKi values ranging from 8.2 to 10.5 across these targets, it is relevant for studies investigating the pharmacological profile of Asenapine. This impurity is important for quality control and characterization in research contexts focused on schizophrenia and bipolar disorder treatments. -
Drug Impurity
Pantoprazole impurity 42 is a characterized impurity of the proton pump inhibitor Pantoprazole. Its presence is critical for pharmaceutical analysis and quality control, ensuring the purity and safety of Pantoprazole formulations. This compound serves as an essential reference standard for the identification and quantification of impurities during drug development and regulatory assessments. -
Drug Impurity
Afatinib impurity 6 is a chemical impurity associated with Afatinib, an irreversible inhibitor targeting the epidermal growth factor receptor (EGFR). This compound is utilized predominantly for the assessment of drug purity and stability in pharmaceutical research. Its presence and characterization are essential for ensuring the quality and efficacy of Afatinib formulations in clinical applications. -
Drug Impurity
Gabapentin acid impurity 4 is a known impurity of Gabapentin acid, primarily utilized in the context of drug quality control. This compound serves as an analytical standard for the identification and quantification of impurities within pharmaceutical formulations. Research applications include stability studies and the assessment of purity in gabapentin-related products, ensuring compliance with regulatory standards. -
Drug Impurity
Aripiprazole impurity 31 is a chemical impurity related to the antipsychotic agent Aripiprazole. Characterized as a potential byproduct in the synthesis of Aripiprazole, this compound is crucial for quality control and regulatory compliance in pharmaceutical development. Its identification and characterization can aid in understanding the compound's stability and overall purity in drug formulations. -
Drug Intermediate
4-Aminomethylindole is a synthetic compound primarily utilized as a drug intermediate in pharmaceutical synthesis. It serves as a versatile building block for the development of various biologically active molecules. This compound is particularly valuable in the synthesis of indole derivatives, which are important in medicinal chemistry and drug discovery applications. -
Drug Impurity
Ellamod impurity 2 is a characterized impurity of the drug Ellamod. This compound is essential for pharmacokinetic studies and ensures the identification and quantification of active and inactive ingredients within drug formulations. It serves as a valuable reference standard in the analysis of drug purity and efficacy, facilitating compliance with regulatory requirements in pharmaceutical development. -
Drug Impurity
1-Acetyl-2-imidazolidinone is identified as a drug impurity associated with clonidine. This compound serves as a valuable reference standard in the analysis and characterization of pharmaceutical formulations. Its role in ensuring the quality and safety of drug products makes it indispensable for research applications focused on impurity profiling and regulatory compliance. -
Drug Impurity
Flecainide Impurity 1, also known as 2-Aminomethylpiperidine, is a chemical impurity associated with the antiarrhythmic agent Flecainide. This compound is primarily utilized in quality control processes and method development within pharmaceutical research. Its characterization is crucial for ensuring the purity and stability of Flecainide formulations, thereby supporting the development of effective cardiac treatments. -
Drug Impurity
Rivaroxaban impurity 68 is a known impurity associated with the anticoagulant Rivaroxaban, primarily affecting its pharmacological profile. This compound is utilized for analytical and quality control purposes in pharmaceutical research and development, particularly in assessing the purity of Rivaroxaban formulations. Its characterization is essential for ensuring compliance with regulatory standards in drug manufacturing and development processes. -
Drug Impurity
Iluoridine Impurity 9 is a known impurity of Iluoridine, a nucleoside analogue. This compound is important for research applications focusing on the purification and characterization of drug substances. Its assessment can aid in understanding the quality and safety profiles of nucleoside-based therapeutics. -
Drug Intermediate
2-Ethylbenzamide serves as an important drug intermediate in the synthesis of a variety of bioactive compounds. With its structural framework, it is utilized in the development of pharmaceuticals and organic synthesis research. This compound plays a crucial role in exploring new medicinal properties and enhancing drug formulations. -
Drug Impurity
Glycopyrronium impurity 3 is an identified impurity of the pharmaceutical compound Glycopyrronium, which acts as a competitive antagonist of muscarinic receptors. This impurity is significant for analytical and quality control studies in drug development, addressing safety and efficacy concerns. Its presence and concentration can impact the overall stability and purity of Glycopyrronium formulations, making it essential for pharmacological research and regulatory compliance. -
Drug Impurity
Montelukast impurity 10 is a chemical impurity related to Montelukast, a leukotriene receptor antagonist. It serves as a reference standard in pharmaceutical research for assessing the purity of Montelukast formulations. Its analysis is critical for ensuring compliance with regulatory standards and enhancing the quality control processes in drug development. -
Drug Intermediate
7-Chloro-2-tetralone serves as a key drug intermediate in the synthesis of various bioactive compounds. This compound is instrumental in the development of pharmaceuticals, particularly in medicinal chemistry endeavors. Its structural features facilitate the construction of complex molecular architectures, making it valuable for research applications in drug discovery. -
Drug Intermediate
Ethyl 1,8-dimethyl-4-oxo-4,5-dihydroimidazo[1,2-a]quinoxaline-2-carboxylate serves as a crucial drug intermediate in the synthesis of diverse bioactive compounds. This reagent is integral to the development of pharmaceuticals, facilitating the formation of complex molecular structures. Its unique imidazoquinoxaline framework supports various biological activities, making it valuable in chemical research and drug discovery applications. -
Drug Intermediate
4-Phenylpyridin-2-ol functions as a versatile drug intermediate, primarily utilized in the synthesis of heterocyclic compounds. Its unique structural properties facilitate various chemical reactions, making it an essential building block in pharmaceutical research and development. This reagent is valuable for researchers focused on developing novel therapeutic agents and enhancing the chemical diversity of drug candidates. -
Drug Intermediate
2'-Hydroxypropiophenone serves as a critical intermediate in the synthesis of 1,2-benzisoxazole prodrugs, including 1,2-benzisoxazole phosphorodiamidates. This compound exhibits significant potential in cancer research, facilitating the exploration of novel therapeutic strategies. Its role in drug development makes it an important tool for studies focused on anticancer efficacy and mechanism of action. -
Drug Impurity
Nimesulide impurity 4, also known as Aminodiphenylether, is a chemical impurity associated with the analgesic and anti-inflammatory drug Nimesulide. This compound is important for assessing the quality and safety of pharmaceutical formulations in drug development and regulatory compliance. It serves as a reference standard for analytical methods aimed at identifying and quantifying impurities in Nimesulide products. -
Drug Intermediate
tert-Butyl 2-{3-[3-(3,4-dimethoxyphenyl)propanoyl]phenoxy}acetate serves as a pivotal drug intermediate in the synthesis of various bioactive compounds. Its structural features facilitate the development of pharmaceuticals with specific therapeutic activities. This reagent is utilized extensively in chemical research, particularly in the fields of medicinal chemistry and drug development. -
Drug Impurity
Apixaban impurity 20 is a chemical impurity associated with the anticoagulant drug Apixaban. Its characterization is crucial for ensuring the purity and safety of Apixaban formulations. This impurity can serve as a reference standard in analytical chemistry, facilitating research and quality control in pharmaceutical development and regulatory compliance. -
Drug Impurity
Ibrutinib Impurity 28 is an impurity associated with Ibrutinib, a selective inhibitor targeting Bruton's tyrosine kinase (BTK). This compound is essential for analytical and quality control applications in pharmaceutical research, aiding in the characterization and assessment of Ibrutinib formulations. The study of impurities such as Ibrutinib Impurity 28 is crucial for ensuring the purity and efficacy of pharmaceutical products. -
Drug Impurity
Montelukast impurity 3 is a detectable impurity associated with the asthma medication Montelukast, a leukotriene receptor antagonist. This compound is important for analytical chemistry studies, specifically in evaluating the purity and stability of Montelukast formulations. Researchers utilize this impurity to assess quality control metrics and ensure compliance with regulatory standards in pharmaceutical development. -
Drug Impurity
Amoxicillin Impurity 7 is a known impurity of the antibiotic compound Amoxicillin, primarily serving as a reference standard in analytical chemistry. This compound is crucial for the assessment of drug purity and quality control in pharmaceutical research. Its characterization aids in understanding the stability and degradation pathways of Amoxicillin, facilitating compliance with regulatory requirements in drug formulation and development. -
Drug Intermediate
6-(2,2,2-Trifluoroethyl)thieno[2,3-d]pyrimidin-4(1H)-one serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical compounds. This compound is integral for the development of therapeutics focusing on various biological targets. Its unique structural features may enhance the efficacy and selectivity of resulting derivatives in drug discovery and development applications. -
Drug Intermediate
2,2-Dimethyl-1-(2-thioxothiazolidin-3-yl)propan-1-one serves as a pivotal drug intermediate in the synthesis of various bioactive compounds. Its structure facilitates the formation of thiazolidine derivatives, which are often utilized in medicinal chemistry research. This reagent is essential for studies focused on compound development and optimization in drug discovery. -
Drug Intermediate
(R)-3-Oxo-cyclopentanecarboxylic acid methyl ester is a synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound exhibits versatility in the formation of biologically active molecules, facilitating the development of potential drug candidates. Its structural features make it valuable for various applications in medicinal chemistry and organic synthesis. -
Drug Impurity
Aripiprazole impurity 23 is a recognized impurity associated with the antipsychotic compound Aripiprazole. This impurity is critical for quality control and analytical studies in pharmaceutical research, allowing for the assessment of drug purity and stability. Its identification and quantification are important for ensuring compliance with regulatory standards and understanding the drug’s profile in formulations.
